These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1110 related articles for article (PubMed ID: 27005906)

  • 1. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailoring novel soft nano-vesicles 'Flexosomes' for enhanced transdermal drug delivery: Optimization, characterization and comprehensive ex vivo - in vivo evaluation.
    Abdel-Messih HA; Ishak RAH; Geneidi AS; Mansour S
    Int J Pharm; 2019 Apr; 560():101-115. PubMed ID: 30753931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
    Al Shuwaili AH; Rasool BK; Abdulrasool AA
    Eur J Pharm Biopharm; 2016 May; 102():101-14. PubMed ID: 26925505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.
    Albash R; El-Nabarawi MA; Refai H; Abdelbary AA
    Int J Nanomedicine; 2019; 14():6555-6574. PubMed ID: 31616143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability.
    Kaithwas V; Dora CP; Kushwah V; Jain S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():10-20. PubMed ID: 28284054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
    Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
    Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
    Al-Mahallawi AM; Abdelbary AA; Aburahma MH
    Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study.
    Morsi NM; Aboelwafa AA; Dawoud MHS
    J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.
    Jain S; Patel K; Arora S; Reddy VA; Dora CP
    Drug Deliv Transl Res; 2017 Apr; 7(2):292-303. PubMed ID: 28116656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study.
    Qadri GR; Ahad A; Aqil M; Imam SS; Ali A
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):139-145. PubMed ID: 26829018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K; Narendar D; Kishan V
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
    Sharma A; Singh AP; Harikumar SL
    Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation.
    Ahmed OAA; Badr-Eldin SM
    Int J Pharm; 2019 Oct; 570():118657. PubMed ID: 31491483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes.
    Prasad PS; Imam SS; Aqil M; Sultana Y; Ali A
    Drug Deliv; 2016; 23(3):1057-66. PubMed ID: 25033041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion.
    Gorain B; Choudhury H; Tekade RK; Karan S; Jaisankar P; Pal TK
    Regul Toxicol Pharmacol; 2016 Dec; 82():20-31. PubMed ID: 27815174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation.
    Albash R; Abdelbary AA; Refai H; El-Nabarawi MA
    Int J Nanomedicine; 2019; 14():1953-1968. PubMed ID: 30936696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QbD based development of proliposome of lopinavir for improved oral bioavailability.
    Patel GM; Shelat PK; Lalwani AN
    Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.